Bottom line
PHSRX vs XLV: the short answer
PHSRX (Putnam Global Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.
XLV is cheaper at 0.08% vs 1.29% — a difference of $121 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +7.5% for PHSRX (reporting dates differ).
Updated Nov 19, 2026
PHSRX vs XLV side by side
| PHSRX | XLV | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Franklin Templeton | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.29% | 0.08% |
| Annual cost per $10k | $129 | $8 |
| 10-yr cost on $10k (prospectus) | $1,556 | $103 |
| Max front load | 0% | None |
| 12b-1 fee | 0.5% | 0.02% |
| 1-yr return | +1.0% | +14.5% |
| 5-yr return (annualized) | +7.5% | +8.1% |
| 10-yr return (annualized) | +7.2% | +9.8% |
| Best quarter | — | +14.5% |
| Worst quarter | — | −12.7% |
| Net assets (fund) | $1.5B | $40.6B |
| Number of holdings | 115 | 65 |
| Portfolio turnover | 67% | 2% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of PHSRX's top 25 holdings also appear in XLV's top 25.
| Holding | PHSRX | XLV |
|---|---|---|
| Eli Lilly & Co. | 13.15% | 16.51% |
| Johnson & Johnson | 8.46% | 10.64% |
| UnitedHealth Group, Inc. | 6.93% | 6.57% |
| AbbVie, Inc. | 6.05% | 7.74% |
| Merck & Co., Inc. | 4.88% | 5.52% |
| Thermo Fisher Scientific, Inc. | 4.50% | 3.24% |
| Intuitive Surgical, Inc. | 4.04% | 2.45% |
| CVS Health Corp. | 2.74% | 2.30% |
| Gilead Sciences, Inc. | 2.63% | 2.73% |
| McKesson Corp. | 2.14% | 1.58% |
| Cardinal Health, Inc. | 2.12% | 0.97% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 2.19% |
| Boston Scientific Corp. | 1.80% | 1.10% |
| Bristol-Myers Squibb Co. | 1.75% | 2.05% |
| HCA Healthcare, Inc. | 1.18% | 1.05% |
Source: SEC Form N-PORT
PHSRX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between PHSRX and XLV?
PHSRX (Putnam Global Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. XLV is cheaper at 0.08% vs 1.29% — a difference of $121 a year per $10,000 invested.
Which is cheaper, PHSRX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both PHSRX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.